HHV-6 reactivation in CAR T-cell recipients is reported to be rare. Our patient cohort (n=119) experienced a seven-fold higher incidence of viraemia than a previous study and 2 encephalitis cases. Further studies are needed to determine risk factors for infection.

Subjects:
Immunobiology and Immunotherapy
This content is only available as a PDF.
Copyright © 2025 American Society of Hematology
2025

Article PDF first page preview

First page of Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients
You do not currently have access to this content.
Sign in via your Institution